Exchange: NASDAQ·Updated 04:15 PM EST
ANIP logo

ANIP ANI Pharmaceuticals Inc

$71.47
$1.48
(2.12%)
Today
Closed $71.47
$0.00
(0.00%)
After Hours
Reported EarningsNov 5
Mkt Cap$1.59B
Vol292,858.00

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
56

Bullish Sentiment

How do you feel about ANIP?

Dy2ski
$ANIP Now proves what incompetent management we have and why the stock has been utter garbage. Bungling the very Cortrophin expansion that they've been pumping all year. Unreal.
1
StocktwitsEarnings
$ANIP Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $2.70 up 32.35% YoY • Reported revenue of $290.78M up 27.64% YoY
1
Dy2ski
$ANIP 52 week LOW! The money and rewards MGMT have been given for this pitiful performance... shameful. Was hoping that Gosebruch was nominated to the BOD to be the adult in the room and to lay the groundwork to sell to a more competent player that wouldn't be bungling Cortrophin but perhaps he's just there to protect the JP Morgan money that's being lended for the Egetis acquisition. Who knows.
Rayvio_News_Filter
$ANIP · $PDPHF 🤝 ANI Pharmaceuticals, Inc. announced an offer to acquire Egetis Therapeutics at SEK 11.25 per share, a 27% premium to the 60-day VWAP, expanding its rare disease business.

Advertisement|Remove ads.